Xiaona Jing

Director, Global CMC And Pharmaceutical Development
NBE Therapeutics
Xiaona Jing
Dr. Xiaona Jing (Director Global CMC & Pharmaceutical Development, NBE-Therapeutics AG), has managed multiple biopharmaceutical CMC projects various from early clinical to the commercial stage, with focus on innovative oncology products such as antibody and ADC. She is experienced in establishing global supply chains for complicated products through outsourcing management of international contract organizations. Currently She is leading the transformation of NBE’s next generation ADC technologies to robust manufacturing platforms through 100% CMC outsourcing involving multiple CDMOs. Before she joined NBE-Therapeutics AG, she has been working on different stage of CMC projects in F. Hoffmann-La Roche AG, Switzerland and Genmab A/S, Denmark.

Sessions

No data was found